Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Endocannabinoids: new targets for drug development.

Di Marzo¹, T Bisogno, L De Petrocellis

¹Istituto per la Chimica di Molecole di Interesse Biologico, Consiglio Nazionale delle Ricerche, Via Toiano 6, 80072, Arco Felice, Napoli, Italy. vdimarzo@icmib.na.cnr.it

Current Pharmaceutical Design

|July 21, 2000

Summary

Cannabinoids, including marijuana

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophages.

Andrology·2016

Same author

The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases.

Expert review of clinical pharmacology·2016

Same author

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.

Cell death & disease·2013

Same author

Analogues of perillaketone as highly potent agonists of TRPA1 channel.

Food chemistry·2013

Same author

Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.

Multiple sclerosis (Houndmills, Basingstoke, England)·2013

Same author

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.

Acta physiologica (Oxford, England)·2011

Area of Science:

Pharmacology
Neuroscience
Biochemistry

Background:

Cannabinoids, active compounds in marijuana, exert effects via CB1 and CB2 receptors.
This led to synthetic cannabinoid drugs with therapeutic potential.
Discovery of endocannabinoids and their mechanisms opened new pharmaceutical research avenues.

Purpose of the Study:

Review ongoing research on endocannabinoids.
Highlight chemical features influencing endocannabinoid-protein interactions.
Explore pharmaceutical applications for various diseases.

Main Methods:

Review of scientific literature on cannabinoid pharmacology.
Analysis of molecular mechanisms of endocannabinoid biosynthesis and inactivation.
Examination of structure-activity relationships for endocannabinoid interactions.

Main Results:

Endocannabinoids are endogenous metabolites activating cannabinoid receptors.
Understanding their pathways is crucial for drug development.
Chemical properties dictate interactions with target proteins.

Conclusions:

Endocannabinoids offer potential for treating nervous and immune disorders, cardiovascular diseases, pain, inflammation, and cancer.
Further research into endocannabinoid pathways and chemical properties is warranted.
Targeting endocannabinoid systems may yield novel therapeutic strategies.

Related Experiment Videos